Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue 8, 2008, Pages 751-758

  Souares, Aurélia ^a   Lalou, Richard ^b   Sene, Ibra ^c   Sow, Diarietou ^c   Le Hesran, Jean Yves ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b Aix Marseille University Marseille   (France)

^c NONE

Author keywords

Adherence; Child; Drug combination therapy; Malaria; Senegal; Treatment outcome

Indexed keywords

ACETYLSALICYLIC ACID; AMODIAQUINE; ANTIBIOTIC AGENT; ANTIPARASITIC AGENT; ANTIPYRETIC AGENT; FANSIDAR; PARACETAMOL; QUININE;

ARTICLE; BLOOD ANALYSIS; CAREGIVER; CHILD; CHILD HEALTH CARE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG OVERDOSE; DRUG URINE LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; RECOMMENDED DRUG DOSE; RURAL AREA; SENEGAL; SINGLE DRUG DOSE; TREATMENT DURATION;

AMODIAQUINE; ANIMALS; ANTIMALARIALS; ATTITUDE TO HEALTH; CAREGIVERS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MEDICATION ADHERENCE; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; RURAL HEALTH; SENEGAL; SULFADOXINE; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM;

EID: 46249100648     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.05.016     Document Type: Article

References (30)

1. Ansah E.K., Gyapong J.O., Agyepong I.A., and Evans D.B. Improving adherence to malaria treatment for children: the use of pre-packed chloroquine vs. chloroquine syrup. Trop. Med. Int. Health 6 (2001) 496-504
2. Basco L.K. Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. Am. J. Trop. Med. Hyg. 70 (2004) 245-250
3. Bloland P.B., Ettling M., and Meek S. Combination therapy for malaria in Africa: hype or hope?. Bull. World Health Organ. 78 (2000) 1378-1388
4. Dahan R., Dahan A., Cadranel J., and Caulin C. Compliance: measurement of adherence and therapeutic follow-up. Therapie 40 (1985) 17-23
5. Depoortere E., Guthmann J.P., Sipilanyambe N., Nkandu E., Fermon F., Balkan S., and Legros D. Adherence to the combination of sulfadoxine-pyrimethamine and artesunate in the Maheba Refugee Settlement, Zambia. Trop. Med. Int. Health 9 (2004) 62-67
6. Dorsey G., Vlahos J., Kamya M.R., Staedke S.G., and Rosenthal P.J. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria. J. Infect. Dis. 188 (2003) 1231-1238
7. Fogg C., Bajunirwe F., Piola P., Biraro S., Checchi F., Kiguli J., Namiiro P., Musabe J., Kyomugisha A., and Guthmann J.P. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am. J. Trop. Med. Hyg. 5 (2004) 525-530
8. Gaye, O., 2002. Surveillance de la chimiorésistance du paludisme au Sénégal. Rapport final de la surveillance des résistances dans 8 sites sentinelles. Programme National de Lutte contre le Paludisme. Ministère de l'hygiène, de la santé et de la prévention, Sénégal.
9. Kofoed P.E., Lopez F., Aaby P., Hedegaard K., and Rombo L. Can mothers be trusted to give malaria treatment to their children at home?. Acta Trop. 86 (2003) 67-70
10. McCombie S.C. Treatment seeking for malaria: a review of recent research. Soc. Sci. Med. 43 (1996) 933-945
11. Mockenhaupt F.P., Ehrhardt S., Dzisi S.Y., Teun Bousema J., Wassilew N., Schreiber J., Anemana S.D., Cramer J.P., Otchwemah R.N., Sauerwein R.W., Eggelte T.A., and Bienzle U. A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria. Trop. Med. Int. Health 10 (2005) 512-520
12. Mount D.L., Nahlen B.L., Patchen L.C., and Churchill L.C. Adaptations of Saker-Solomons test: a simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bull. World Health Organ. 67 (1989) 295-300
13. Nuwaha F. The challenge of chloroquine-resistant malaria in sub-Saharan Africa. Health Policy Plan. 16 (2001) 1-12
14. Nwanyanwu O.C., Redd S.C., Ziba C., Luby S.P., Mount D.L., Franco C., Nyasulu Y., and Chitsulo L. Validity of mother's history regarding antimalarial drug use in Malawian children under five years old. Trans. R. Soc. Trop. Med. Hyg. 90 (1996) 60-68
15. Okonkwo P.O., Akpala C.O., Okafor H.U., Mbah A.U., and Nwaiwu O. Compliance to correct dose of chloroquine in uncomplicated malaria correlates with improvement in the condition of rural Nigerian children. Trans. R. Soc. Trop. Med. Hyg. 95 (2001) 320-324
16. Osterberg L., and Blaschke T. Adherence to medication. N. Engl. J. Med. 4 (2005) 353 487-497
17. Pussard E., Verdier F., and Blayo M.C. Simultaneous determination of chloroquine, amodiaquine and their metabolites in human plasma, red blood cells, whole blood and urine by column liquid chromatography. J. Chromatogr. 374 (1986) 111-118
18. Qingjun L., Jihui D., Laiyi T., Xiangjun Z., Jun L., Hay A., Shires S., and Navaratnam V. The effect of drug packaging on patients' compliance with treatment for Plasmodium vivax malaria in China. Bull. World Health Organ. 76 Suppl. 1 (1998) 21-27
19. Reilley B., Abeyasinghe R., and Pakianathar M.V. Barriers to prompt and effective treatment of malaria in northern Sri Lanka. Trop. Med. Int. Health 7 (2002) 744-749
20. Rwagacondo C.E., Niyitegeka F., Sarushi J., Karema C., Mugisha V., Dujardin J.C., Van Overmeir C., van den Ende J., and D'Alessandro U. Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine-pyrimethamine combined with artesunate. Am. J. Trop. Med. Hyg. 68 (2003) 743-747
21. Sokhna C.S., Trape J.F., and Robert V. Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine. Parasite 8 (2001) 243-250
22. Souares A., Lalou R., Sene I., Sow D., and Le Hesran J.Y. Knowledge and practices among the health workers from the Thies region with regard to new malaria treatment policies. Sante Publique 2 (2006) 299-310
23. UNICEF. Malaria and children: progress in intervention coverage (2007), United Nations Children's Fund, New York and Roll back Malaria, Geneva
24. White N.J. Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 41 (1999) 301-308
25. White N.J. Antimalarial drug resistance. J. Clin. Invest. 113 (2004) 1084-1092
26. WHO, 2001. Antimalarial Drug Combination Therapy. Report of a WHO Technical Consultation. World Health Organization, Geneva, WHO/RBM/2001.35.2001.
27. WHO, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. World Health Organization, Geneva, WHO/HTM/RBM/2003.50.
28. Yepez M.C., Zambrano D., Carrasco F., and Yepez R.F. The factors associated with noncompliance with antimalarial treatment in Ecuadorian patients. Rev. Cubana Med. Trop. 52 (2000) 81-89
29. Yeung S., and White N.J. How do patients use antimalarial drugs? A review of the evidence. Trop. Med. Int. Health 10 (2005) 121-138
30. Zongo I., Dorsay G., Rouamba N., Dokomajilar C., Lankoande M., Ouedraogo J.B., and Rosenthal P.J. Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. Am. J. Trop. Med. Hyg 73 (2005) 826-832